EDGAR Filing Documents for 0001140361-22-016245

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001140361-22-016245

Filing Date

2022-04-27

Accepted

2022-04-27 16:23:25

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	ny20002542x2_defa14a.htm	DEFA14A	18559
2		ny20002542x2_nc01.jpg	GRAPHIC	2773139
3		ny20002542x2_nc02.jpg	GRAPHIC	2016252
	Complete submission text file	0001140361-22-016245.txt		5277506

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37587 | Film No.: 22859938
SIC: 2834 Pharmaceutical Preparations